PE20020291A1 - Profarmacos para ligandos del receptor nmda - Google Patents
Profarmacos para ligandos del receptor nmdaInfo
- Publication number
- PE20020291A1 PE20020291A1 PE2001000820A PE2001000820A PE20020291A1 PE 20020291 A1 PE20020291 A1 PE 20020291A1 PE 2001000820 A PE2001000820 A PE 2001000820A PE 2001000820 A PE2001000820 A PE 2001000820A PE 20020291 A1 PE20020291 A1 PE 20020291A1
- Authority
- PE
- Peru
- Prior art keywords
- piperidin
- hydroxy
- formula
- pro
- drugs
- Prior art date
Links
- HOKKHZGPKSLGJE-GSVOUGTGSA-N N-Methyl-D-aspartic acid Chemical compound CN[C@@H](C(O)=O)CC(O)=O HOKKHZGPKSLGJE-GSVOUGTGSA-N 0.000 title abstract 2
- 229940002612 prodrug Drugs 0.000 title abstract 2
- 239000000651 prodrug Substances 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 5
- 150000002148 esters Chemical class 0.000 abstract 2
- 102000004868 N-Methyl-D-Aspartate Receptors Human genes 0.000 abstract 1
- 108090001041 N-Methyl-D-Aspartate Receptors Proteins 0.000 abstract 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 230000001154 acute effect Effects 0.000 abstract 1
- 150000001412 amines Chemical class 0.000 abstract 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000004770 neurodegeneration Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/42—Oxygen atoms attached in position 3 or 5
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/59—Hydrogenated pyridine rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
SE REFIERE A UN COMPUESTO DE FORMULA I DONDE R ES -C(O)(CH2)nC(O)OH, GRUPO a, DONDE R1 ES -N(R2)(R3), R2 Y R3 SON H, ALQUILO INFERIOR, AMINA TERCIARIA, -P(O)(OH)2, -C(O)(CH2)nNHC(O)(CH2)nN(R2)(R3) Y n ES 1-4. SON COMPUESTOS PREFERIDOS ESTER MONO-{(3S,4S)-4-[2-(4-BENCIL-3-HIDROXI-PIPERIDIN-1-IL)-ETANSULFONIL]-FENILICO DEL ACIDO SUCCINICO, ESTER (3S,4S)-4-[2-(4-BENCIL-3-HIDROXI-PIPERIDIN-1-IL)-ETANSULFONIL]-FENILICO DEL ACIDO 4-MORFOLIN-4-ILMETILBENZOICO, ESTER (3S,4S)-4-[2-(4-BENCIL-3-HIDROXI-PIPERIDIN-1-IL)-ETANSULFONIL]-FENILICO DEL ACIDO 4-(4-METIL-PIPERAZIN-1-ILMETIL)-BENZOICO, ENTRE OTROS. SE REFIERE TAMBIEN A UN PROCEDIMIENTO PARA LA PREPARACION Y COMPUESTOS INTERMEDIOS . LOS COMPUESTOS DE FORMULA I PUEDEN SER EMPLEADOS COMO PROFARMACOS DEL COMPUESTO DE FORMULA II LOS CUALES SON BLOQUEADORES SELECTIVOS DEL RECEPTORES DEL NMDA (N-METIL-D-ASPARTATO) Y SON UTILES PARA EL TRATAMIENTO FORMAS AGUDAS DE NEURODEGENERACION COMO ALZHEIMER, PARKINSON, HUNTINGTON
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00117918 | 2000-08-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20020291A1 true PE20020291A1 (es) | 2002-04-17 |
Family
ID=8169594
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2001000820A PE20020291A1 (es) | 2000-08-21 | 2001-08-16 | Profarmacos para ligandos del receptor nmda |
Country Status (35)
| Country | Link |
|---|---|
| US (1) | US6407235B1 (es) |
| EP (1) | EP1313703B1 (es) |
| JP (1) | JP4162991B2 (es) |
| KR (1) | KR100589991B1 (es) |
| CN (1) | CN1227230C (es) |
| AR (1) | AR030373A1 (es) |
| AT (1) | ATE386022T1 (es) |
| AU (2) | AU2001285894B2 (es) |
| BR (1) | BR0113348A (es) |
| CA (1) | CA2419279C (es) |
| CY (1) | CY1107937T1 (es) |
| CZ (1) | CZ303319B6 (es) |
| DE (1) | DE60132782T2 (es) |
| DK (1) | DK1313703T3 (es) |
| EC (1) | ECSP034489A (es) |
| EG (1) | EG24293A (es) |
| ES (1) | ES2299508T3 (es) |
| HR (1) | HRP20030125B1 (es) |
| HU (1) | HU229802B1 (es) |
| IL (1) | IL154254A0 (es) |
| JO (1) | JO2289B1 (es) |
| MA (1) | MA26947A1 (es) |
| MX (1) | MXPA03001311A (es) |
| MY (1) | MY136065A (es) |
| NO (1) | NO324941B1 (es) |
| NZ (1) | NZ523990A (es) |
| PA (1) | PA8525601A1 (es) |
| PE (1) | PE20020291A1 (es) |
| PL (1) | PL204215B1 (es) |
| PT (1) | PT1313703E (es) |
| RS (1) | RS51467B (es) |
| RU (1) | RU2272027C2 (es) |
| SI (1) | SI1313703T1 (es) |
| WO (1) | WO2002016321A1 (es) |
| ZA (1) | ZA200300894B (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SK12842002A3 (sk) * | 2000-03-21 | 2003-02-04 | The Procter And Gamble Company | Heterocyklický vedľajší reťazec obsahujúci N-substituované inhibítory metaloproteáz a farmaceutický prípravok s ich obsahom |
| US6713490B2 (en) | 2002-04-26 | 2004-03-30 | Pfizer, Inc. | 3,4-dihydroquinolin-2(1H)-one compounds as NR2B receptor antagonists |
| KR20080086514A (ko) * | 2005-12-19 | 2008-09-25 | 메틸진 인크. | 항진균제의 활성을 증가시키기 위한 히스톤 데아세틸라제억제제 |
| CA2672192A1 (en) | 2006-12-19 | 2008-06-26 | Methylgene Inc. | Inhibitors of histone deacetylase and prodrugs thereof |
| US8796330B2 (en) * | 2006-12-19 | 2014-08-05 | Methylgene Inc. | Inhibitors of histone deacetylase and prodrugs thereof |
| CN105683180B (zh) | 2013-11-05 | 2020-01-21 | 阿斯利康(瑞典)有限公司 | Nmda拮抗剂前药 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69420053T2 (de) * | 1994-01-31 | 1999-11-25 | Pfizer Inc., New York | Neuroprotektive chroman verbindungen |
| DE4410822A1 (de) | 1994-03-24 | 1995-09-28 | Schering Ag | Neue Piperidin-Derivate |
| TW340842B (en) * | 1995-08-24 | 1998-09-21 | Pfizer | Substituted benzylaminopiperidine compounds |
| TW498067B (en) | 1996-07-19 | 2002-08-11 | Hoffmann La Roche | 4-hydroxy-piperidine derivatives |
| TWI254043B (en) | 1999-06-08 | 2006-05-01 | Hoffmann La Roche | Ethanesulfonyl-piperidine derivatives having good affinity to N-methyl-D-aspartate (NMDA) receptor |
-
2001
- 2001-08-16 PA PA20018525601A patent/PA8525601A1/es unknown
- 2001-08-16 PE PE2001000820A patent/PE20020291A1/es not_active Application Discontinuation
- 2001-08-16 US US09/931,431 patent/US6407235B1/en not_active Expired - Lifetime
- 2001-08-17 AR ARP010103939A patent/AR030373A1/es active IP Right Grant
- 2001-08-17 MY MYPI20013876A patent/MY136065A/en unknown
- 2001-08-19 JO JO2001136A patent/JO2289B1/en active
- 2001-08-20 HU HU0301548A patent/HU229802B1/hu not_active IP Right Cessation
- 2001-08-20 RU RU2003107572/04A patent/RU2272027C2/ru not_active IP Right Cessation
- 2001-08-20 NZ NZ523990A patent/NZ523990A/en not_active IP Right Cessation
- 2001-08-20 RS YUP-130/03A patent/RS51467B/sr unknown
- 2001-08-20 JP JP2002521197A patent/JP4162991B2/ja not_active Expired - Fee Related
- 2001-08-20 IL IL15425401A patent/IL154254A0/xx not_active IP Right Cessation
- 2001-08-20 CN CNB01814361XA patent/CN1227230C/zh not_active Expired - Fee Related
- 2001-08-20 DE DE60132782T patent/DE60132782T2/de not_active Expired - Lifetime
- 2001-08-20 PT PT01965201T patent/PT1313703E/pt unknown
- 2001-08-20 AT AT01965201T patent/ATE386022T1/de active
- 2001-08-20 MX MXPA03001311A patent/MXPA03001311A/es active IP Right Grant
- 2001-08-20 AU AU2001285894A patent/AU2001285894B2/en not_active Ceased
- 2001-08-20 BR BR0113348-9A patent/BR0113348A/pt not_active Application Discontinuation
- 2001-08-20 PL PL361387A patent/PL204215B1/pl unknown
- 2001-08-20 HR HR20030125A patent/HRP20030125B1/xx not_active IP Right Cessation
- 2001-08-20 EP EP01965201A patent/EP1313703B1/en not_active Expired - Lifetime
- 2001-08-20 ES ES01965201T patent/ES2299508T3/es not_active Expired - Lifetime
- 2001-08-20 EG EG20010906A patent/EG24293A/xx active
- 2001-08-20 AU AU8589401A patent/AU8589401A/xx active Pending
- 2001-08-20 CA CA002419279A patent/CA2419279C/en not_active Expired - Fee Related
- 2001-08-20 CZ CZ20030492A patent/CZ303319B6/cs not_active IP Right Cessation
- 2001-08-20 DK DK01965201T patent/DK1313703T3/da active
- 2001-08-20 WO PCT/EP2001/009561 patent/WO2002016321A1/en not_active Ceased
- 2001-08-20 KR KR1020037002485A patent/KR100589991B1/ko not_active Expired - Fee Related
- 2001-08-20 SI SI200130812T patent/SI1313703T1/sl unknown
-
2003
- 2003-01-31 ZA ZA200300894A patent/ZA200300894B/en unknown
- 2003-02-19 NO NO20030781A patent/NO324941B1/no not_active IP Right Cessation
- 2003-02-20 EC EC2003004489A patent/ECSP034489A/es unknown
- 2003-02-21 MA MA27052A patent/MA26947A1/fr unknown
-
2008
- 2008-05-08 CY CY20081100485T patent/CY1107937T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20020657A1 (es) | Derivados de amida de piperidinas 1,4-disustituidas de formula (i) | |
| MX2023012477A (es) | Compuestos heterociclicos. | |
| PE20020272A1 (es) | N-oxidos de derivados de 4-fenil-piridina como prodrogas de los antagonistas del receptor de neuroquinina 1 (nk-1) | |
| PE20001599A1 (es) | Procedimientos e intermedios para preparar compuestos anticancerosos | |
| ECSP034475A (es) | Derivados de 4-fenil-piridin como antagonistas del receptor de neuroquinina-1 | |
| PE20011228A1 (es) | Derivados de piridopirimidina o iminopirimidina utiles para el tratamiento de enfermedades neurodegenerativas | |
| JOP20220089A1 (ar) | عملية لتحضير 2-سيانو إثيل (4s)-4-(4-سيانو-2-مثوكسي فنيل)-5-إثوكسي-2، 8-ثنائي مثيل-1، 4-ثنائي هيدرو-1، 6-نفثيريدين-3-كربوكسيلات بفصل المركبات الراسيمية بواسطة إسترات حمض طرطريك صنوية فراغية | |
| AR058554A1 (es) | Compuestos heterociclicos nitrogenados de 6 miembros sustituidos, metodos para su preparacion, composiciones farmaceuticas que los contienen y su uso en el tratamiento de enfermedades mediadas por mglur5. | |
| PE20070051A1 (es) | Serin-amidas sustituidas con heteroaroilo | |
| PE20221420A1 (es) | Procedimiento fotoquimico para la preparacion de (4r,4s)-4-(4-ciano-2-metoxifenil)-5-etoxi-2,8-dimetil-1,4-dihidro-1,6-naftiridin-3-carboxamida | |
| CR10671A (es) | Compuestos azabiciclicos como inhibidores de la recaptacion de monoaminas | |
| MA35886B1 (fr) | Dérivés de benzylsulfanilamide utilisés comme inhibiteurs -2 mogat | |
| PE20020291A1 (es) | Profarmacos para ligandos del receptor nmda | |
| CL2021000171A1 (es) | Procedimiento y productos intermedios para la preparación de bilastina | |
| ES2046671T3 (es) | Un procedimiento para la preparacion de tetrahidroimidazo(1,4)benzodiazepin-2-tionas. | |
| MX2019000035A (es) | Composicion de amina util para producir espuma de poliuretano. | |
| MX2020013827A (es) | Proceso de preparacion de compuestos triciclicos. | |
| YU144790A (sh) | 5-alkil-1,3-4-tiadiazoli, postupak za njihovu izradu i primena kao sredstvo za suzbijanje štetočina | |
| DE3171116D1 (en) | Arylamine derivatives, process for their preparation and their use as microbicides | |
| EA200200611A1 (ru) | Новые тетрагидропиридины, способ их получения и содержащие их фармацевтические композиции | |
| TW200724535A (en) | Oxazine disulfide dyes | |
| AR043245A1 (es) | Composicion insecticida de incienso y emulsion y procedimiento para prepararla | |
| PE20051059A1 (es) | Concentrados de aditivos para carburantes y lubricantes, que contienen por lo menos un derivado de antraquinona como sustancia marcadora | |
| MX2021000226A (es) | Nuevo proceso para la preparacion de diamidas antranilicas. | |
| GB0320738D0 (en) | Novel process |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |